Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer
Authors
Keywords
Ovarian cancer, Enzyme-linked immunoassays, Ascites, Cancer treatment, Macrophages, Primary cells, Cell proliferation, Prognosis
Journal
PLoS One
Volume 10, Issue 2, Pages e0118080
Publisher
Public Library of Science (PLoS)
Online
2015-02-07
DOI
10.1371/journal.pone.0118080
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted anti-vascular therapies for ovarian cancer: current evidence
- (2013) M Hall et al. BRITISH JOURNAL OF CANCER
- Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment
- (2013) E. M. Dijkgraaf et al. CANCER RESEARCH
- Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse
- (2013) Silke Reinartz et al. INTERNATIONAL JOURNAL OF CANCER
- Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies
- (2013) Parvin Ataie-Kachoie et al. PLoS One
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
- (2012) Eveline M. Dijkgraaf et al. CURRENT PHARMACEUTICAL DESIGN
- Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells
- (2012) Yue Wang et al. CYTOKINE
- Inflammation and ovarian cancer
- (2012) Antonio Macciò et al. CYTOKINE
- Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression
- (2012) Toshiki Oguro et al. EUROPEAN JOURNAL OF CANCER
- Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer
- (2012) Qingchun Cai et al. FASEB JOURNAL
- Possible Role for Tocilizumab, an Anti–Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia
- (2012) Katsutoshi Ando et al. JOURNAL OF CLINICAL ONCOLOGY
- Paraneoplastic Thrombocytosis in Ovarian Cancer
- (2012) Rebecca L. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
- (2011) Jermaine Coward et al. CLINICAL CANCER RESEARCH
- Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma
- (2009) S. Shinriki et al. CLINICAL CANCER RESEARCH
- A High-Affinity Fully Human Anti-IL-6 mAb, 1339, for the Treatment of Multiple Myeloma
- (2009) M. Fulciniti et al. CLINICAL CANCER RESEARCH
- Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors
- (2009) Kyoko Kawamura et al. PATHOLOGY INTERNATIONAL
- Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas
- (2008) M Colomiere et al. BRITISH JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now